India to Iran: Vinblastine Export Trade Route
India has recorded 3 verified shipments of Vinblastine exported to Iran, representing a combined trade value of $70.0K USD. This corridor is served by 1 active Indian exporters, with an average shipment value of $23.3K USD. The leading Indian exporter is SP ACCURE LABS PRIVATE LIMITED, which accounts for 100% of total export value with 3 shipments worth $70.0K USD. On the buying side, HIRAD PHRAMED is the largest importer in Iran with $42.4K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Iran Vinblastine corridor is one of India's established pharmaceutical export routes, with 3 shipments documented worth a combined $70.0K USD. The route is dominated by SP ACCURE LABS PRIVATE LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's vinblastine manufacturing sector.
Across 1 active suppliers, the average shipment value stands at $23.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (15%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 31.2%, placing it at rank #20 among India's top vinblastine export destinations globally.
On the import side, key buyers of Indian vinblastine in Iran include HIRAD PHRAMED, HIRAD PHARMED UNIT. HIRAD PHRAMED is the single largest importer with 2 shipments valued at $42.4K USD.
Route Characteristics
- Average transit20 days
- Peak seasonQ4
- Primary modeMulti-modal
- Top portHYDERABAD AIR
Market Position
- Global rank#20
- Annual growth+31.2%
- Demand growth+26.1%
- Regulatory ease66/100
Top 10 Indian Vinblastine Exporters to Iran
Showing top 10 of 1 Indian suppliers exporting Vinblastine to Iran, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SP ACCURE LABS PRIVATE LIMITED Avg $23.3K per shipment | 3 | $70.0K | 100.0% |
This table shows the top 10 of 1 Indian companies exporting vinblastine to Iran, ranked by total trade value. The listed exporters are: SP ACCURE LABS PRIVATE LIMITED. SP ACCURE LABS PRIVATE LIMITED is the dominant supplier with 3 shipments worth $70.0K USD, giving it a 100% market share.
Top 10 Vinblastine Importers in Iran
Showing top 10 of 2 known buyers in Iran receiving Vinblastine shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian vinblastine in Iran include HIRAD PHRAMED, HIRAD PHARMED UNIT. The largest importer is HIRAD PHRAMED, accounting for $42.4K USD across 2 shipments — representing 61% of all vinblastine imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | HIRAD PHRAMED | 2 | $42.4K | 60.7% |
| 2 | HIRAD PHARMED UNIT | 1 | $27.5K | 39.3% |
Top 10 Vinblastine Formulations Imported by Iran
Showing top 10 of 2 product formulations shipped on the India to Iran Vinblastine route, ranked by trade value
Iran imports a wide range of vinblastine formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — VINB SPAL 10 (VINBLASTINE SULPHATE FOR INJECTION USP 10MG/VIAL) — accounts for $42.4K USD across 2 shipments. A total of 2 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | VINB SPAL 10 (VINBLASTINE SULPHATE FOR INJECTION USP 10MG/VIAL) | 2 | $42.4K | 60.7% |
| 2 | VINB SPAL 10 VINBLASTINE SULFATE FOR INJECTION USP 10MG/VIAL | 1 | $27.5K | 39.3% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 66% sea for bulk, 15% air for urgent orders.
Top Ports of Origin
HYDERABAD AIR handles the highest volume with 3 shipments. Transit time averages 20 days by sea.
Market Dynamics
India's vinblastine exports to Iran are driven primarily by a handful of large-scale manufacturers. SP ACCURE LABS PRIVATE LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Iran benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SP ACCURE LABS PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $23.3K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as vinb spal 10 vinblastine sulfate for injection usp 10mg/vial, suggesting that buyers in Iran tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, HIRAD PHRAMED is the largest importer with 2 shipments worth $42.4K USD — representing 61% of all vinblastine imports from India on this route.
Route Statistics
- Trade Volume
- $70.0K
- Avg. Shipment
- $23.3K
- Suppliers
- 1
- Buyers
- 2
- Transit (Sea)
- ~20 days
- Annual Growth
- +31.2%
Related Analysis
Other Vinblastine Routes
Unlock the Full India to Iran Vinblastine Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 3 shipments on this route.
Frequently Asked Questions — India to Iran Vinblastine Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Vinblastine to Iran?
The leading Indian exporters of Vinblastine to Iran are SP ACCURE LABS PRIVATE LIMITED. SP ACCURE LABS PRIVATE LIMITED holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Vinblastine exports from India to Iran?
India exports Vinblastine to Iran worth approximately $70.0K USD across 3 recorded shipments. The average value per shipment is $23.3K USD.
Q Which ports does India use to ship Vinblastine to Iran?
The most active port of origin is HYDERABAD AIR with 3 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 66% of shipments going by sea and 15% by air.
Q How long does shipping take from India to Iran for Vinblastine?
The average transit time for Vinblastine shipments from India to Iran is approximately 20 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Iran Vinblastine trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 31.2% with demand growth tracking at 26.1%. The route is ranked #20 among India's top Vinblastine export destinations globally.
Q How many suppliers are active on the India to Iran Vinblastine route?
There are currently 1 active Indian suppliers exporting Vinblastine to Iran. The market is moderately concentrated with SP ACCURE LABS PRIVATE LIMITED accounting for 100% of total shipment value.
Q Who are the main importers of Vinblastine from India in Iran?
The leading importers of Indian Vinblastine in Iran include HIRAD PHRAMED, HIRAD PHARMED UNIT. HIRAD PHRAMED is the largest buyer with 2 shipments worth $42.4K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Iran export trade corridor identified from Indian Customs (DGFT) records for Vinblastine.
- 2.Supplier/Buyer Matching: 1 Indian exporters and 2 importers in Iran matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 3 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3 Verified Shipments
1 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists